Rentokil Initial (RTO)

 

RTO Share PerformanceMore

52 week high299.10 23/08/17
52 week low204.50 14/12/16
52 week change 80.40 (36.88%)
4 week volume84,414,483 28/07/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Change to Director's details

RNS Number: 6992O Rentokil Initial PLC 22 August 2017 22 August 2017 Rentokil Initial plc Change to Director's details Pursuant to Listing Rule 9.6.14(2), Rentokil Initial plc (the "Company") announces that it has been informed that Angela Seymour-Jackson, a Non-Executive Director , has been appointed as a Non-Executive Director of PageGroup plc with effect fr...

Broker Forecast - Deutsche Bank issues a broker note on Rentokil Initial PLC

Deutsche Bank today reaffirms its buy investment rating on Rentokil Initial PLC (LON:RTO) and raised its price target to...

Director Deals - Rentokil Initial PLC (RTO)

Jeremy Townsend, Financial Director, exercised 464,655 shares in the company on the 3rd August 2017 at a price of 0.00p. T...

Director Deals - Rentokil Initial PLC (RTO)

Jeremy Townsend, Financial Director, sold post-exercise 219,156 shares in the company on the 3rd August 2017 at a price of ...

Director/PDMR Shareholding

RNS Number: 1716N Rentokil Initial PLC 04 August 2017 Rentokil Initial plc (the Company) The Company hereby announces that Jeremy Townsend (a person discharging managerial responsibility) has exercised his award of 464,655 shares granted under the Rentokil Initial plc Performance Share Plan (PSP) in March 2014, with 219,156 of these shares being sold at a sh...

Director Declaration

RNS Number: 6134M Rentokil Initial PLC 31 July 2017 31 July 2017 Rentokil Initial plc Change to Director's details Pursuant to Listing Rule 9.6.14(2), Rentokil Initial plc (the "Company") announces that it has been informed that the Company's Chairman, John McAdam, has been appointed as a Non-Executive Director and Senior Independent Director of Cobham plc w...

Broker Forecast - Barclays Capital issues a broker note on Rentokil Initial PLC

Barclays Capital today reaffirms its overweight investment rating on Rentokil Initial PLC (LON:RTO) and set its price targ...

AstraZeneca plummets on failed MYSTIC trial

AstraZeneca (AZN) crashed 16.2% to 42.83 on its failed MYSTIC clinical trial. The pharma giant said that using immuno-th...

Fundamental DataMore

P/E ratio32.469
EPS9.19
Dividend yield1.129 %

Latest discussion posts More

  • Re: Years

    Bought these last Nov, keeping myself. Mainly as most of business is abroad and Brexit proof.
    27-Jul-2017
    pinchers
  • Years

    I would not sell since you have been through some v bad years but the new management has transformed the company and, in my view, the best is yet to come.
    27-Jul-2017
    tejo
  • years

    Just checked and I have held these for 17 years...... Maybe its time to sell????
    27-Jul-2017
    latife

Users' HoldingsMore

Users who hold Rentokil Initial also hold..
LLOYDS GRP.45%
VODAFONE GRP.29%
GLAXOSMITHKLINE27%
BARCLAYS25%
BP25%

Codes & Symbols

ISINGB00B082RF11
SymbolsRTO, LSE:RTO, RTO.L, RTO:LN, LON:RTO, XLON:RTO